{"url":"https://lda.senate.gov/api/v1/filings/fefc6b72-e9bd-4406-8d54-9f28e5ffd734/","filing_uuid":"fefc6b72-e9bd-4406-8d54-9f28e5ffd734","filing_type":"RR","filing_type_display":"Registration","filing_year":2012,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/fefc6b72-e9bd-4406-8d54-9f28e5ffd734/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gary Martin, CFO","dt_posted":"2012-10-19T11:30:05.793000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1101 PENNSYLVANIA AVE, NW","registrant_address_2":"SUITE 700","registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":72576,"url":"https://lda.senate.gov/api/v1/registrants/72576/","house_registrant_id":35932,"name":"FABIANI & COMPANY","description":"Global trade","address_1":"800 Maine Ave SW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MONICA CORTES","contact_telephone":"+1 202-767-7386","dt_updated":"2023-05-09T22:25:10.947000-04:00"},"client":{"id":166306,"url":"https://lda.senate.gov/api/v1/clients/166306/","client_id":1005914,"name":"SIALIX INC.","general_description":"Develops products based on new biological discoveries of non-human sialic acids","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2012-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Secure DoD and DHHS funding for GlycoBiology Research","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":45284,"prefix":null,"prefix_display":null,"first_name":"MELISSA","nickname":null,"middle_name":null,"last_name":"DUPREE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Secure DoD and DHHS funding for GlycoBiology Research","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":45284,"prefix":null,"prefix_display":null,"first_name":"MELISSA","nickname":null,"middle_name":null,"last_name":"DUPREE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}